An important negative control mechanism in the signaling of Epidermal Growth Factor (EGF) is the endocytosis and subsequent degradation of activated EGF receptors. Eps15 and its related partner Eps15R play a key role in clathrin-mediated endocytosis of transmembrane receptors. Upon EGF stimulation of the cell, Eps15 becomes both phosphorylated on tyrosine residues and monoubiquitinated. Although tyrosine phosphorylation of Eps15 has been implicated in EGF receptor internalization, the function of Eps15 ubiquitination is not known. Using a mutational approach, we have found that the second Ubiquitin-Interacting Motif (UIM) of Eps15 and Eps15R is essential for their ubiquitination. This UIM motif partially overlaps with the recently characterized Nuclear Export Signal (NES) in Eps15. We show that these two overlapping motifs have different structural requirements with respect to NES versus ubiquitination signal activity. Our data demonstrate that the UIM does not contain the ubiquitin acceptor site but functions as a recruitment site for the ubiquitination machinery leading to the monoubiquitination of both Eps15 and Eps15R. 
Introduction
The interaction of growth factors with their cognate receptors does not only trigger intracellular transduction of mitogenic signals, it also induce events leading to endocytosis and subsequent degradation of activated receptors. This process is called receptor down regulation and is the most important negative control mechanism for growth factors signaling (1) . Eps15 and Eps15R are both essential components involved in the internalization of plasma membrane receptors via the clathrinmediated internalization pathway (2) (3) (4) . Eps15 was initially identified as a substrate of the EGF receptor kinase (5) , while Eps15R (Eps15 Related) was identified as a Crk binding protein (6) . So far, the function of Eps15 has been shown to be restricted to the early events leading to the formation of clathrin-coated pits where Eps15 is thought to recruit AP-2 complexes (7-9).
Eps15 and Eps15R are structurally organized in three domains. The N-terminal domain (domain I) contains three EH domains, the second domain (DII) is a coiled-coil region involved in Eps15 oligomerization (10) . The C-terminal domain (DIII) contains a proline-rich motif which interacts in vitro with the SH3 domain of Crk (6) . The multiple DPF (Asp-Pro-Phe) repeats present in the third domain of Eps15 and Eps15R are involved in the binding to the α-subunit of the clathrin adaptor protein complex AP-2 (11, 12) . The third domain of Eps15 also contains the major tyrosine phosphorylation site of Eps15, Tyr850. Tyrosine phosphorylation on Tyr850 is specifically required for EGF receptor internalization, but not for transferrin receptor internalization (13) . This tyrosine phosphorylation site is not present in Eps15R, indicating that these two closely related proteins are not solely dedicated to the same functions.
such as endocytosis, targeting of plasma membrane proteins for degradation in the vacuole/lysosome, virus budding or histone regulation (15) . Ubiquitin conjugation is carried out by successive enzymatic reactions involving a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2) and a ubiquitin ligase (E3). E3-ubiquitin ligases, either alone or in combination with a bound E2, catalyze the formation of an isopeptide bond between the C-terminal glycine of ubiquitin and the ε-amino group of a lysine residue on the target protein. E3 enzymes are responsible for the important step of substrate recognition. They bind to ubiquitination signals which are usually small primary sequence motifs (16) (17) (18) . The high specificity of substrate recognition is an essential feature of the ubiquitination machinery since a wide variety of proteins become ubiquitinated in the cell.
To get more insight into the function of Eps15 monoubiquitination, we have analyzed the process of Eps15 ubiquitination in more detail. In this study, we have found that both Eps15 and Eps15R are subjected to monoubiquitination. We have investigated the molecular determinants that are critical for Eps15 and Eps15R ubiquitination. A mutational approach was carried out to determine which domain of both Eps15 isoforms is essential for ubiquitination. For this purpose, we have developed an in vivo ubiquitination assay using Cos-1 cells. We reasoned that if a deletion mutant was not ubiquitinated, it would indicate that either the ubiquitination site(s) or the recognition motif for the ubiquitination machinery has been removed, or both. This approach allowed us to identify a new ubiquitination signal that does not contain the ubiquitination site(s) but targets both Eps15 and 
Materials and Methods

Cell lines
Cos-1 cells, Her14 cells (NIH 3T3 cells stably transfected with human EGF-receptor cDNA), and BHK-21 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco, UK) supplemented with 7.5% fetal calf serum (Gibco, UK), 2mM L-glutamine, 100 U/ml penicillin, 100µg/ml streptomycin. Cells were grown at 37°C in a 5% CO 2 humidified atmosphere.
Plasmids
The pMT123 vector containing the HA-ubiquitin cDNA was obtained from Prof. Dr. G. Strous (Utrecht, The Netherlands) and has been described by others (19) . The cDNA of Myc-Reps2 cloned in pcDNA4.TO was obtained from Dr. L. Blok (Rotterdam, Netherlands). The cDNA of human Eps15 subcloned into the EGFP-C2 vector was a kind gift of Dr. A. Benmerah (Paris, France). The fulllength cDNA of mouse Eps15 was subcloned from pCEV-eps15 (a kind gift from Dr. C. Schumacher, Novartis, New Jersey, USA) into pcDNA3.1zeo (Invitrogen). An adaptor encoding the FLAG-tag (MDYKDDDDKGS) was inserted into the KpnI and BamHI sites of pCDNA3.1zeo-Eps15. The FLAG-Eps15 cDNA was subcloned into the bicistronic vector pIREShyg (Clontech 645 to 897) and replacing it by a PCR product encoding for residues 645 to 813 followed by a stop codon. A similar stategy was used to obtain the pCDNA3.1zeo-FLAG-Eps15-∆C26 lacking the last 7 All the FLAG-Eps15 constructs containing point mutations were created using the QuickChange Site Directed Mutagenesis kit (Stratagene) using the pMT2SM-FLAG-Eps15 vector as template. The multiple Lysine to Arginine mutants of FLAG-Eps15 were obtained in successive steps.
The mutants FLAG-Eps15-2KR (K818R/K820R), FLAG-Eps15-L872A/L875A, FLAG-Eps15-L883A/L885A, FLAG-Eps15-I887A/L889A and FLAG-Eps15-E879A/E881A/D882A were generated by introducing simultaneously the 2 or 3 desired mutations into the primers.
The full length cDNA of mouse Eps15R was subcloned from pCEV-eps15R (a kind gift from Dr. C. Schumacher, Novartis, New Jersey, USA) into pcDNA3.1zeo and an adaptor encoding the Myc tag (MEQKLISEEDL) was inserted into the HindIII and NarI sites of pCDNA3.1zeo-Eps15R. The pCDNA3.1zeo-Myc-Eps15R-∆III (truncated at a.a. 661) was obtained by removing the BamHI/XbaI fragment and replacing it by an adaptor encoding DPF 661 followed by a stop codon. The pCDNA3.1zeo-Myc-Eps15R-∆C90 lacking the last 90 residues i.e. truncated at A817 was obtained by cutting out the fragment BamHI/XbaI (coding for a.a. 659 to 907) and replacing it by a PCR product encoding residues 659 to 817 followed by a stop codon. A similar stategy was used to obtain the pCDNA3.1zeo-Myc-Eps15R-∆C25 lacking the last 25 residues i.e. truncated at R882. The Myctagged CT1-R and CT2-R fragments coding for a.a. 818-907 and a.a. 774-907 of Eps15R
(respectively last 90 and last 134 residues) were obtained by PCR and subcloned into pCDNA3.1zeo.
All constructs were checked by DNA sequencing (Eurogentec, Belgium).
Transient and stable transfection
Cells were transfected using Fugene-6 reagent according to the instructions of the manufacturer 
In vivo ubiquitination assay
Cos-1 cells seeded in 35 mm dishes were grown to 50% confluency and co-transfected with a mixture of plasmids encoding HA-Ubiquitin (HA-Ub), FLAG-Eps15 or Myc-Eps15R. After 24 h, cells were either left untreated or stimulated with 50 ng/ml EGF for 10 min at 37ºC. Cells were washed with cold phosphate-buffered saline (PBS) and lysed in 300 µl ice-cold RIPA buffer (20 mM Tris-HCl pH7.4, 0.15 M NaCl, 0.5% Triton X-100, 0.1% SDS, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF) , 1 mM benzamidine, 1 µg/ml aprotinin, 10 mM NaF, 1 mM Leica fluorescence microscope and a laser scanning confocal imaging system using a ×63 objective.
All pictures shown correspond to similar settings in order to compare fluorescence intensities. The Scion Image software was used to obtain inverted black and white images.
Results
Both Eps15 and Eps15R are monoubiquitinated
To study the structural requirements for Eps15 ubiquitination, we created a FLAG-tagged murine Eps15 and several deletion mutants. We first investigated whether FLAG-Eps15 could undergo EGF-induced monoubiquitination in Her14 cells in a similar manner as endogenous Eps15 (14). We established a stable cell line expressing FLAG-Eps15 (Her14-FLAG-Eps15) using a Immunodetection of the same immunoblot with an anti-FLAG antibody did show only one band, with a lower molecular weight, corresponding to the non-ubiquitinated form of FLAG-Eps15. The ubiquitinated species, of higher molecular weight, were detected with the anti-FLAG antibody when chemiluminescent detection was carried out for longer time (not shown). We estimate that ~20% of the FLAG-Eps15 population is ubiquitinated.
Stimulation of Cos-1 cells with EGF did not have any effect on Eps15 ubiquitination (Fig. 1B) .
Increasing the expression level of EGFR by co-expression of a human EGFR did not influence the In order to assess whether Eps15R displays similar ubiquitination pattern as Eps15, we studied the ubiquitination of a transiently transfected myc-tagged murine Eps15R (Myc-Eps15R) in Cos-1 cells. Myc-Eps15R displayed a similar ubiquitination pattern as Eps15 as shown by the presence of two bands detected on the anti-HA immunoblot (Fig .1C) . The ubiquitination of Myc-Eps15R was not due to the presence of the Myc-tag (which contains one Lysine, a potential ubiquitination acceptor site) because another myc-tagged protein, Myc-Reps2 was not ubiquitinated using the same ubiquitination assay. Similarly to Eps15, ubiquitination of Eps15R was not affected by EGF stimulation in Cos-1 cells (not shown).
The C-terminus of Eps15 and Eps15R is critical for their ubiquitination
In order to determine which part of Eps15 is involved in its ubiquitination, we created several deletions and point mutations in the context of the FLAG-tagged Eps15 construct (summarized in Figure 2 ) and studied their ubiquitination using the in vivo ubiquitination assay. A mutant lacking the first structural domain of Eps15, i.e. devoided of the three EH domains (FLAG-Eps15-∆I, lacking a.a.
1-350) and a mutant lacking the central coiled-coil domain (FLAG-Eps15-∆II, lacking a.a. 361-643)
were still ubiquitinated, whereas truncation of the third domain of Eps15 (FLAG-Eps15 ∆III, truncated at position 648) resulted in a major loss of ubiquitination (Fig 3A) . The equivalent truncation in Eps15R (myc-Eps15R ∆III, truncated at position 661) led to a complete loss of ubiquitination (Fig. 3A) .
In order to investigate further the molecular determinant regulating Eps15 and Eps15R ubiquitination, we created smaller C-terminal deletion mutants of both Eps15 and Eps15R. Figure 3B shows that the truncation of the last 84 amino acid of Eps15 (FLAG-Eps15-∆C84) resulted in a major loss of ubiquitination and the equivalent truncation in Eps15R, deleting the last 90 amino acids (MycEps15R-∆C90) resulted in a total loss of ubiquitination.
The last 84 residues of Eps15 do not contain ubiquitin acceptor sites
The loss of ubiquitination of the FLAG-Eps15-∆C84 mutant indicates that the last 84 residues of Eps15 contain a molecular determinant essential for ubiquitination. This molecular determinant can be the ubiquitin acceptor site(s), the binding site for the ubiquitination machinery (E3-ubiquitin ligase, alone or in combination with an E2 enzyme) or both. In order to analyze whether the C-terminal 84 residues of Eps15 contain the ubiquitin attachment site(s), we substituted all the lysine residues located in this part of the molecule (K818, K820, K837, K861, K891) for arginine residues, in the context of the full-length FLAG-Eps15. The ubiquitination of the resulting mutant (FLAG-Eps15-5K→R) was similar to that of the wild-type FLAG-Eps15 (data not shown) demonstrating that the last 84 amino acids of Eps15 do not contain the ubiquitination site(s).
The last 84 residues of Eps15 contain a binding site for the ubiquitination machinery
Two strategies were applied to test whether the last 84 residues of Eps15 contain a binding site for the ubiquitination machinery. In the first approach, we reasoned that if the C-terminal part of . Similarly, CT1-R and CT2-R were also able to inhibit the ubiquitination of full-length FLAG-Eps15 (Fig. 4B) .
As a second strategy to demonstrate that the last 84 a.a. of Eps15 contain a binding site for the ubiquitination machinery, we tested whether this domain could re-establish the ubiquitination of a non-ubiquitinated truncated mutant of Eps15R. We therefore created a chimera (myc-Eps15R-∆C90 + 5K→R) composed of myc-Eps15R-∆C90 to which we added the last 84 a.a. of Eps15 (a.a. 814-897
corresponding to the missing a.a 818-907 of Eps15R) containing the 5 K→R mutation. This particular mutant was used for this experiment to exclude the possibility that the possible recovery of ubiquitination was due to the presence of a substrate lysine in the last 84 a.a. added to the C-terminus of myc-Eps15R-∆C90. Figure 5 shows that the chimera myc-Eps15R-∆C90 + 5K→R is ubiquitinated indicating that the last 84 a.a. of Eps15, containing no lysine, was able to re-establish ubiquitination on Eps15R-∆C90. In conclusion, our results demonstrate that the last 84 residues of Eps15 contain a binding site for the ubiquitination machinery.
The ubiquitination signal of Eps15 is a UIM partially overlapping with the nuclear export signal
In order to map more precisely the binding site for the ubiquitination machinery, we created a truncated form of Eps15 devoided of the last 26 a.a. (FLAG-Eps15-∆C26, lacking a.a 872-897) and the equivalent truncated Eps15R (myc-Eps15R-∆C25, lacking a.a 883-907). These truncations resulted in a dramatic reduction of ubiquitination of both Eps15 and Eps15R (Fig.6A) suggesting that the E3-ligase binding site is located in this part of the C-terminus of the two molecules. Interestingly, the last 25 amino acids of Eps15 contain a classical leucine-rich nuclear export signal (NES) involved in CRM-1 binding in a leucine-dependent manner (20, 21) . Moreover, this part of Eps15 and Eps15R is particularly enriched in hydrophobic leucine and isoleucine residues, all conserved in Eps15R except I894 (Fig. 6B ). Strikingly, a very similar leucine-rich motif (LALAL) present in the proteasome subunit S5a was shown to bind polyubiquitin chains (22) . This motif is part of a ubiquitininteracting motif (UIM) identified in S5a and in several endocytic proteins. Two UIMs are present at the C-terminus of Eps15 and Eps15R. Interestingly, the second UIM is located in the last 25 amino acids of Eps15 and Eps15R (23) . To investigate the functionality of this UIM in the ubiquitination of Eps15, we replaced the leucine/isoleucine residues by Alanine in the context of the full-length FLAGEps15. Four different mutants were generated: L872A/L875A; L883A/L885A; I887A/L889A and I894A. As shown in Fig. 6C , mutation of L872 and L875 to Alanine did not affect Eps15 ubiquitination nor did the mutation of I894 to Alanine. Interestingly, these three leucine/isoleucine residues are not part of the UIM (23) . In contrast, mutation of UIM residues L883A/L885A and I887A/L889A resulted in a complete loss of ubiquitination, indicating that the UIM is critical for Eps15 ubiquitination. However, single point mutations of each of these four residues (L883A; L885A;
I887A; L889A) did not affect ubiquitination of Eps15 (data not shown).
Comparison of Eps15 and Eps15R sequences surrounding the leucine-rich motif shows that the motif Q 878 EQED 882 is conserved in both proteins (Fig. 6B) . Some leucine-rich protein-protein interaction motifs have been shown to require a charged environment (24) . Moreover, these negatively charged residues are conserved in most UIMs (23) . We examined whether the negatively charged residues were involved in the binding of the ubiquitination machinery. Four mutants were generated in the context of FLAG-Eps15: E879A, E881A, D882A and a triple mutant E879A/E881A/D882A. As shown in Fig. 6D , single mutation of acidic residues did not affect Eps15 ubiquitination, whereas the triple mutant EED→A was significantly less ubiquitinated than wild-type Eps15. This result shows that a negatively charged environment is important for the leucine-rich motif to recruit the ubiquitination machinery.
Our results show that residues L883, L885, I887 and L889 are critical for Eps15 ubiquitination.
These residues together with I894, were previously shown to be essential NES residues, i.e. involved in the binding with CRM-1 (21). We therefore studied the relation between nuclear localization of Eps15 and the inhibition of Eps15 ubiquitination. Non-ubiquitinated Eps15 mutants L883A/L885A, and I887A/L889A displayed partial nuclear localization (Fig. 6E ) which is in agreement with previous studies (21) . The Eps15 mutant I894A was also partially relocalized to the nucleus as expected (21) .
This I894A Eps15 mutant is however fully ubiquitinated showing that nuclear accumulation is not strictly correlated with a loss of ubiquitination.
Discussion
Using an in vivo ubiquitination assay, we have demonstrated that the last 26 C-terminal residues of Eps15, and the equivalent last 25 residues of Eps15R, contain a molecular determinant necessary for the ubiquitination of both proteins. Competition experiments using the last 90 residues of Eps15R (CT1-R) as well as transfer of the last 84 residues of Eps15-5K→R to a non-ubiquitinated deletion mutant of Eps15R demonstrated that this C-terminal domain of Eps15(R) is able to recruit the ubiquitination machinery. Using site directed mutagenesis (see Fig. 2 for an overview), we have identified the signal responsible for Eps15 ubiquitination. This novel ubiquitination signal has been previously identified as a UIM (23). It does not contain the ubiquitination site and is conserved in Eps15R.
The ubiquitination signal of Eps15 involves residues L883, L885, I887 and L889 which are also essential residues of its Nuclear Export Signal (NES). However, the ubiquitination signal is not strictly identical to the NES of Eps15. Residue I894 which is essential for the NES activity (our results and (21)) is not critical for the ubiquitination of Eps15. This suggests that the overlapping leucine-rich ubiquitination signal and the NES are not functionally linked. Moreover, Eps15R is ubiquitinated in a similar way to Eps15, but Eps15R does not contain a functional NES (21) . Acidic residues proximal to the leucine-rich motif are important for Eps15 ubiquitination. A negatively charged environment seems to be required for the leucine-rich motif to recruit the ubiquitination machinery. Such charged leucine-rich protein-protein interaction motifs have been found in proteins involved in the co-activation of nuclear receptors. Their consensus sequence is LxxLL, reminding of the Eps15 leucine-rich motif LxLxIxL (24) (25) (26) . A very similar motif (LYLYLQL) has been found in the transcription factor RFX5 and is essential for its transactivation function (27) . Furthermore, the LALAL motif in proteasome subunit S5a responsible for polyubiquitin binding is flanked by negatively charged residues (22) .
The ubiquitination signal of Eps15 does not resemble any other known ubiquitination signal
( (28) Alternatively, E3 ligases that are self-ubiquitinated, such as Mdm2 and E6AP (34,35) may be involved. In this case, a ubiquitin moiety conjugated to a lysine residue of the E3 could mediate the recruitment of the ligase by the UIM of the substrate. Further investigation is needed to unravel the molecular mechanism involved in the recruitment of the E3 ligase by the UIM.
Our findings indicate that the ubiquitination signal of Eps15 does not contain the ubiquitin acceptor site. Indeed, mutation of all lysine residues located in the last 84 a.a. of Eps15 does not affect Eps15 ubiquitination. Similar lysine to arginine mutations at positions 584, 593, 596, 660 and 690 did not alter Eps15 ubiquitination. These lysine residues were analyzed since they surround high scored PEST sequences of Eps15 (36) . Lysines located within or adjacent to PEST sequences have been described to function as ubiquitin acceptor sites (37, 38) . We cannot rule out the possibility that the It is known from studies in yeast that mono-or oligo-ubiquitination can target plasma membrane proteins for internalization (43, 44) . Moreover, ubiquitin itself carries an internalization signal in its three-dimensional structure (45) . Ubiquitination of Eps15 might therefore participate in its endocytic function. It was shown by others that a mutant of Eps15 lacking the last 47 amino acid,
i.e. lacking the ubiquitination signal, is normally targeted to clathrin-coated pits, does not inhibit clathrin-coated pit assembly and has no effect on transferrin receptor internalization (7). In accordance with these results, overexpression of the non-ubiquitinated Eps15 mutants L883A/L885A
and I887A/L889A did not affect transferrin receptor internalization (unpublished observations).
Together, these results suggest that ubiquitination of Eps15 is not required for its endocytic function.
However, as it is the case for the tyrosine phosphorylation of Eps15, which is specifically dedicated to the EGF receptor internalization (13) This suggests a role for Eps15 in later stages of endocytosis. A new intriguing role for Eps15 in transcriptional regulation has recently been proposed (20) . In that perspective, it is remarkable that leucine-rich motifs similar to the ubiquitination signal of Eps15 are found in co-activators of transcription factors (24) (25) (26) (27) . The identification of the ubiquitination signal of Eps15 and Eps15R
should enable us to investigate further the function served by their monoubiquitination. * * * * * * * * * * * * *** * * * * * * * * * * * * * * * * *** * * * *
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